Profile
Chad May is currently the Chief Scientific Officer at Orum Therapeutics, Inc., starting in 2026.
Formerly, Dr. May was the Chief Scientific Officer at Serotiny, Inc.
Chad May active positions
| Companies | Position | Start |
|---|---|---|
| ORUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 04/01/2026 |
Former positions of Chad May
| Companies | Position | End |
|---|---|---|
Serotiny, Inc.
Serotiny, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research | Chief Tech/Sci/R&D Officer | 31/12/2025 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Orum Therapeutics, Inc.
Orum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in the research and development of pharmaceuticals for cancer and immune diseases | Health Technology |
Serotiny, Inc.
Serotiny, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research | Commercial Services |
- Stock Market
- Insiders
- Chad May
















